Chong Kun Dang Pharmaceutical Corp. (185750.KS) KSC

Currency In KRW

AD

Valuation

Market Cap1.09T
Enterprise Value1.24T
P/E Ratio10.79
PEG Ratio0.35
Price/Sales Ratio0.48
Price/Book Ratio0.88
Enterprise/Revenue0.62
Enterprise/EBITDA8.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.04
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.69T
Revenue/Share129,157.38
Gross Profit517.23B
EBITDA125.37B
Net Income77.83B
Diluted EPS5,845.54

Balance Sheet

Total Cash329.3B
Total Cash/Share23,857.12
Total Debt437.44B
Total Debt/Equity0.43
Current Ratio2.04
Book Value Per Share73,776.12

Price History

52-Week Change-20.02
52-Week High98,100
52-Week Low63,000
Moving Average 50 Days67,224
Moving Average 200 Days78,774.5

Statistics

Average Volume22,036
Shares Outstanding13.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate500
Trailing Annual Dividend Yield0.77
Payout Ratio0.08
Last Split Factor21:20
Last Split DateDecember 27, 2024
AD